Syndrome of Inappropriate Antidiuresis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-12-13
Clinical Trial Update: Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study [Phase 2, Phase 3]
Phase 2/3 trial evaluating empagliflozin for SIADH-related hyponatremia has completed.